Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Mouth Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Tongue Neoplasms 1 Solid Tumor 1 Skin Lesion 1 Renal Colic 1 Rectal Neoplasms 1 Pregnancy, Ectopic 1 Postoperative Complications 1 Pneumonia 1 Pleural Effusion 1 Phlebitis 1 Pancreatic Neoplasms 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Lymphoma, AIDS-Related 1 Liver Neoplasms 1 Kidney Neoplasms 1 Gastrointestinal Neoplasms 1 Cysts 1 Cholecystitis 1 Brain Neoplasms 1 Arachnodactyly 1 Abortion, Spontaneous 1

Interventions

Capecitabine 41 Oxaliplatin 39 Fluorouracil 29 Leucovorin 23 Radiotherapy 21 Cetuximab 14 Bevacizumab 14 Irinotecan 13 Nivolumab 12 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Surgical Procedures, Operative 8 Folfox protocol 8 Drug Therapy 8 pembrolizumab 7 Radiotherapy, Intensity-Modulated 7 Chemoradiotherapy 7 Biopsy 7 trifluridine tipiracil drug combination 6 Radiation 6 tislelizumab 5 sintilimab 5 regorafenib 5 dehydroftorafur 5 X-Rays 5 Surveys and Questionnaires 5 Sigmoidoscopy 5 Endoscopy 5 Consolidation Chemotherapy 5 spartalizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Ultrasonography × 1 year × Clear all

NCT04927897 2025-07-28

DETECT

Maastricht Radiation Oncology

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡